Eton Pharmaceuticals (ETON) Shares Outstanding (Weighted Average) (2017 - 2025)

Eton Pharmaceuticals has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $26.9 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $26.9 million, up 3.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $26.9 million (up 3.91% YoY), and the FY2025 annual result was $26.9 million, up 3.91% from the prior year.
• Shares Outstanding (Weighted Average) came in at $26.9 million for Q4 2025 at Eton Pharmaceuticals, roughly flat from $26.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $26.9 billion in Q2 2025 to a low of $25525.0 in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $25.1 million (2022), against an average of $1.4 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 99.9% in 2023 and jumped 38756025.68% in 2025, its largest moves.
• Eton Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $25.2 million in 2021, then retreated by 0.24% to $25.1 million in 2022, then rose by 1.99% to $25.6 million in 2023, then advanced by 0.97% to $25.9 million in 2024, then advanced by 3.91% to $26.9 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $26.9 million (Q4 2025), $26.9 million (Q3 2025), and $26.9 billion (Q2 2025), per Business Quant data.